JPRN-UMIN000025620Completed未知
A comparative clinical trial on the effects of atorvastatin 10mg and atorvastatin 5mg/ ezetimibe 10mg in type 2 diabetic patients with nephropathy and hypercholesterolemia - Comparison of the effects of atorvastatin high dose and atorvastatin/ezetimibe combination therapy
Misaki Naika Clinic0 sites40 target enrollmentStarted: January 13, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
Compared with the atorvastatin group, the rate of reduction of non HDL-C and LDL-C was significantly larger in the ezetimibe group. Renal marker and safety did not differ between the two groups.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Patients with hypersensitivity of the test drugs 2) Patients with hepatic dysfunction(AST or ALT>=100U) 3) Patients with a past history of cerebrovascular or cardiovascular event 4) Patients with secondary or drug-induced hyperlipidemia 5) Patients with familial hypercholesterolemia 6) Pregnant or possibly pregnant patients, patients on lactation 7) Patients with insulin treatment 8) Patients with fibrate treatment 9) Inappropriate patients for this study according to the judgment of Investigator
Investigators
Similar Trials
Completed
Phase 3
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)Lupus Erythematosus, SystemicNCT00065806Laura Schanberg221
Withdrawn
Not Applicable
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.HypertensionNCT00656331University of New Mexico
Terminated
Phase 4
The Effect of Lipitor on Aortic StenosisAortic Valve StenosisNCT00590135The Cleveland Clinic59
Completed
Phase 4
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHDCardiovascular DiseasesNCT00159835Pfizer8,600
Completed
Phase 4
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With HypercholesterolemiaHypercholesterolemiaNCT00141141Pfizer's Upjohn has merged with Mylan to form Viatris Inc.383